chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Wednesday Positive; cough; mild fever; arm was sore; This is a spontaneous report from a contactable consumer or other non hcp.  A 60-years-old female patient received bnt162b2  (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: Unknown) via an unspecified route of administration on 03Apr2021 as single dose for covid-19 immunisation . The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated that, on saturday received first dose of vaccine. Monday PCR was done and it was negative PCR. Rapid test was done on Tuesday it was negative again the patient done test on Wednesday it was positive. She asked the vaccine could give the False Positive test. On Saturday after shot mild fever, arm was sore and on Monday had cough. The outcome of the events reported as unknown.  The action taken in response to the events  for bnt162b2 was not applicable.  Follow-up recived on 09Apr2021: New information added, New events added (mild fever, arm was sore and cough). Lab tests were added.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I began having chills, fatigue, and headache, minor sore throat and very wet cough. I experienced significant head cold symptom. I was very sick for three days and mildly sick for two. The cough persisted for two weeks after I tested negative. I did take an antiviral that wasn't Paxlovid, it was Molnupiravir.
Noticed a rash around the injection site today (9 days after my first dose). It wasn't itchy or painful, just a raised red splotchy area with uneven boundaries. Looked like hives. I noticed it at ~6pm, but it's possible it was there earlier. I've been wearing long sleeves all week. Also experienced a headache today, but unrelated factors may have caused this; I was wearing a strong perfume at work that sometimes gives me headaches.
Initial information received on 08-Mar-2019 regarding an unsolicited valid non-serious case received from a physician via other company (Pfizer). This case involves patient (with unknown age and gender) who experienced allergy to tetanus and diphtheria toxoids, while he/she received vaccine DIPHTHERIA AND TETANUS TOXOIDS. The patients past medical history, concomitant medication and family history were not provided. On an unknown date, the patient received injection of suspect DIPHTHERIA AND TETANUS TOXOIDS produced by unknown manufacturer lot number not reported via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious allergy to tetanus and diphtheria toxoids (allergy to vaccine) with unknown latency following the administration of DIPHTHERIA AND TETANUS TOXOIDS. On an unknown date, the patient developed a non-serious rash with unknown latency following the administration of DIPHTHERIA AND TETANUS TOXOIDS. Lab data was not provided. Final diagnosis was allergy to tetanus and diphtheria toxoids. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for allergy to tetanus and diphtheria toxoids and as Unknown for rash. Documents held by the sender: none.
Initial report received on 28 August 2007 from a physician. A 15-year-old female patient, with no concurrent illnesses, and who has a past medical history of "ADHD" (attention deficit hyperactivity disorder) being treated with Adderall, had received a right deltoid dose of Menactra, lot number U8534, on 27 August 2007. The evening after vaccination the patient experienced sight pain at the right deltoid area and the following day, the pain got progressively worse to include pain and stiffness in the right shoulder. Her right arm was very tender but had no redness. She also experienced back pain and a temperature of 99.4 degrees Fahrenheit. No diagnostic testing was performed. The patient was "prescribed" Motrin. At the time of this report, the patient had not recovered.
Information has been received from a RN concerning a pt who on 02/12/04 was vaccinated with a dose of MMRII. On 02/18/04 the pt developed a rash. On 02/23/04 the rash was still present. No lot # or further information was available at that time. Unspecified medical attention was sought. There was no product quality complaint. The reporter also indicated that the pt's were vaccinated via the inappropriate route (WAES # 0402USA01852).  Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 27 year old patient. On approximately 03-SEP-2014 (reported as week ago from the time of report) the patient less than 50 years was vaccinated with ZOSTAVAX lot # K007548 with expiration date: 23-AUG-2015 (also reported as K00754B) 0.65 ml, once, route of administration subcutaneous. No adverse effect reported. Patient did not seek medical attention. Additional information has been requested.
Vaccines yesterday. This am rectal temp 101.6. Baby is fussy according to mom.
I started to experience severe chest pains, starting slowly at around 9 PM.  Took a baby aspiringand 2 tums- but the pain started to worsen.  Thought I was experiencing a heart attack, so around 12:30 AM woke my husband to go to the hospital  Changed, took 2 more tums and the chest pain started to subside.  Did not go to the hospital.  Question 1- Should I get the 2nd Shingrix shot?  Question 2- I am not sure whose brand of the Quadrivalent Flu Shot I received, but was told by some health professionals both vaccines should not have been administered together.  I contacted my health care provider (who I prefer not to identify) and was told it was perfectly safe.  I now have concerns about the Covid vaccine and am scared to  death to take the 2nd Shingrix shot.  I need some professional guidance as to how to proceed.  You should also know I tested positive for Covid 19 in April 2020.
J & J vaccine and still struggling to recover.  High BP, Racing Heart, Heart Palpitations, Full body tremors, nauseau, migraines, vision loss, chest pain, severe brain fog and memory loss, leg numbness, disoriented,  insomnia, fatigue, still pain at injection site, loss of gall bladder, gut issues, depression,  teeth pain, blacking out, join & muscle aches, histamine intolerance, shortness of breath, adverse reactions to supplements & essential oils I have used for years!  Been to multiple drs and spent well over $30,000 trying to recover and still not well.
Headache, Myalgia, Fever, Fatigue, chills Narrative:  Symptoms began at 7pm on 1-26-21 and carried on til 1-27-21, Employee had to leave work
Day of injection, developed pruritus of back. Worsened the day after and started seeing a papular rash over multiple areas of back.
Redness and warmth at injection site. Advised to use cold pack and Benadryl and follow up with doctor if not resolving.
On day 10 after receiving Moderna vaccination, the BCG vaccination scar I received as a baby swelled up. It has since stayed red, swollen and lightly itchy.
Rash on chest and neck; Delayed reaction; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on chest and neck) and SKIN REACTION (Delayed reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on chest and neck) and SKIN REACTION (Delayed reaction). At the time of the report, RASH (Rash on chest and neck) and SKIN REACTION (Delayed reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Vaccine given around 11:05 am and around 11:10 am patient began feeling dizzy and stated left side of face felt numb. Patient denied any generalized itching, swelling of lips/face/throat, shortness of breath, or abdominal cramping. No generalized redness or hives or severe wheezing observed. Around 11:25 am patient stated she felt dizzy but also started to feel "weak". Patient continued to deny development of any anaphylactic symptoms. BP in right arm was 138/102 with pulse of 101. Patient advised BP approx 28 days ago was 107/72. Around 11:30 am patient advised skin on throat felt itchy. See continuation page
fever; headache; trouble speaking; unable to walk; unable to breath; crooked fingers/ twisted fingers; This is a spontaneous report from a contactable consumer (patient). A 15-years-old male patient received first dose of bnt162b2 (BNT162B2, BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EW0178) via an unspecified route of administration, administered in arm left on 15Jun2021 09:00 as dose 1, single and dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot Number: EW0186) as dose 2, single for COVID-19 immunization (Age at vaccination 15 years). Medical history included asthma; food allergy Known allergies to the shrimp, sinus disorder. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid tested post vaccination. On 07Jul2021 01:00 patient experienced fever, headache, trouble speaking, unable to walk, unable to breath and crooked fingers/ twisted fingers. Therapeutic measures were taken as a result of all AE includes treatment with vein treatment solumedrol and Panadol, vendria. AE resulted in Emergency room / department or emergencies. The outcome for all events was recovered on an unspecified date in 2021  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a consumer, as part of a marketing research program refers to a 14 year old female daughter's friend. In 2011, the patient was vaccinated with the second dose of GARDASIL (dose, route and lot number were not reported). No concomitant medications were reported. In 2011, the patient experienced "distorted skin" reaction at injection site and stated puffy for a couple months after 2nd shot of GARDASIL. The outcome of the events was reported as recovered (probably resolved before 3rd shot). It was noted that the reporter was unsure if the adverse event re-appear after restarting GARDASIL. MRK 30809-V503 HCC Qualitative Research. Additional information has been requested.
Employee started to feeling tingling to right leg 4 hours after vaccination. Tingling traveled to left leg followed by rash. Tingling and rash spread from bilateral legs to bilateral arms. Employee took Benadryl at 10:19 PM states had no effect for tingling and rash. Employee still has symptoms at this time.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The pharmacist was informed by an unspecified physician, that the patient received the first dose of GARDASIL (lot number and expiration date not reported) (dose and route not reported) several years ago and then a second dose of GARDASIL on 03-MAY-2013. Concomitant therapy was not reported. No adverse effect reported. Additional information has been requested.
Report A0384625A describes the occurrence of mercury poisoning in an 18 month old male who received hep B vaccine (Engerix B). This report was received as a result of litigation proceedings and has not been confirmed by a physician or other healthcare professional. The subject "was born a perfectly normal, healthy boy whose apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, the subject achieved every developmental milestone anticipated of all normally developing children until the age of 18 months." The subject received injection of Engerix B on 11/29/95 (1817A2) and 2/2/96 (1943A2). The subject also received Tetramune 11/29/95, 2/2/96, 4/22/96 and 5/5/97; Hib Titer 5/5/97; hep B vaccine 1/7/99; and Pnu-Imune 23 10/20/97. The attorney alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Information received on 10/22/02 did not specify the outcomes of these events. The events "mercury poisoning" and "developmental regression" in this report are considered medically serious (OMIC).
Headaches/ear pain/body aches/joint and nerve pain/muscle ache/menstrual disruption/clotting
Initial report received from a physician on 26-August-2005. A male patient, who is also a physician (age not reported), experienced severe pain in the arm where the vaccine was administered and slight fever (exact temperature not reported) 12-24 hours after he received DECAVAC (lot number not reported) on 23-August-2005. The patient stated possibly lymph node involvement. The symptoms persisted and the patient was unable to life his arm. At the time of report, the patient had not received. Follow-up information received on 31-August-2005. The patient is a 39 year old male physician. On 23-August-2005, the eve of vaccination, the patient experienced pain at the injection site, subjective fever, chills and "felt warm to touch". 48 hours later, the patient developed axillary lymph node swelling, severe pain and arm weakness. On the seventh day post injection, the patient had a 10 x 6 cm area of redness, warmth and swelling at the injection site that covered 70% of the upper arm. The patient was treated for infection. Follow-up information received on 06-September-2005. The patient stated that the swelling of the deltoid had decreased however he still had significant swelling in the axillary area. He complained that when his arm was not elevated, he experienced tingling, pain and swelling in the arm.
Swelling to (R) deltoid at site of vaccination. Also had sensation of choking and throat closing. Approximately 2 days later.
Pt developed stiffness and soreness in left arm and left side of neck.  Numbness down to left hand into fingers.  Pt also experienced a headache.
I took the GARDASIL shot series.  It didn't cause major problems, but when I took the second shot around the above date I noticed a change in my vaginal discharge.  The shot caused me to get bacterial vaginosis.  I had it for nine months till I figured out there was a problem because a month before hand I took myself off birth control and I thought my body was just going through changes.  I talked to my doctor and he told me it wasn't the GARDASIL shot, so I took the third shot in the series.  It immediately caused the bacterial vaginosis yet again.  It's not that it's serious, but every woman should know that this is a possible side effect and may be they should prepare themselves.
side effects that included a rash on face and chest/redness on my chest; red mask across my eyes; ill; weak; This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of red rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced red rash, eye red, unwell and weakness. On an unknown date, the outcome of the red rash, eye red, unwell and weakness were recovered/resolved.   It was unknown if the reporter considered the red rash, eye red, unwell and weakness to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR011103  Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient had received 1st dose of Shingles shot and experienced side effects that included a rash on his/her face and chest. Ever since then, every time he/she got ill or weak, he/she had the same symptoms as a red mask across eyes and redness on his/her chest. The follow-up could not be possible as no contact details were available. For tolerance to 2nd dose, refer case US2022AMR011103
Its possible that the vaccination may have super charged my existing eczema and, then, as I tried to get relief from the eczema, I tried a new medication. I don't know if I blame the vaccine, but I do wonder if it somehow my eczema behaved differently. Swelling, weeping, like elephant skin on one ankle, throbbing. Treating it a little bit and getting some relief from the medication. The eczema threw itself to my hand and migrated. it looks a lot like hand eczema. It also looks like Kaposi sarcoma. It created dark polka dotted pattern on my hand. It's kind of a peeling and painful mess. It is getting better, but I don't know. Overall, I wonder if the vaccine causes some internal inflammation in me. It caused the diverticulosis and now the eczema on my palm. The eczema on my ankle just got so thick and like a runaway train.
2"x2" lymph node in L axilla - appeared 24h +/- after Tdap vaccine injected in L deltoid.
About 5 hours after the shot, I began to have soreness in the upper part of my arm around the injection site.  This soreness continued and got a little worse over the next 18 hours.  It was not unbearable, nor did I take any medication for it.  It just felt like I had been punched in the arm on the outside of my arm.
knot on arm; bruises; swelling; redness; Initial information received on 12-Nov-2019 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional.  Medical history, concurrent condition and concomitant medication was unknown.  This case involves a 71 years old female patient who experienced knot on arm (PT: Large arm swelling), swelling (PT: Swelling), bruises (PT: bruise) and redness (PT: erythema), INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ285AA Expiration date: 02-Jun-2020) on 01-Nov-2019.  on an unknown date, (latency unknown) patient had a severe reaction with Fluzone HD and also experienced a knot on arm (PT: Large arm swelling), swelling (PT: Swelling), bruises (PT: bruise) and redness (PT: erythema).Her physician described it as a trauma.  corrective treatment was Cortisone and event outcome was Unknown at the time of reporting.
Had a cold sweat; Rapid heartrate; Went to ER on Jan 2 - decreased magnesium; IV therapy - magnesium infusion (January 2st) - ER  - Put me on a magnesium supplement; the symptoms resolved a few days later;  Saw Dr on January 5th After 2nd dose of  - had rapid heartrate for second dose but it was only periodically for two days and I didn't seek medical care
Pt came into pharmacy with complaint of bump on arm and a diffuse red flat rash. The bump had started going down by the time that she came into the store.
PATIENT WAS SWEATING. SHE LOOKS PALE AND WAS COLD. SHE INDICATED HER SIGHT BLURRED. AFTER 45 MINUTES SHE WAS FINE.
Second shot was on 4/22/2019. Had new anaphylactic  reaction to fish on  5/1/19.  had significant fecal motor weakness 5/13/1019,left flank pain for a week starting 6/2/2019. Left flank  swelling starting on 6/2/2019 and continuing until present
cheeks and tongue felt full-monitor- push fluids, v/s, sent to nearest ER  for evaluation
Fever lasting 48 hours, highest measured temperature 103.6, with possibility of higher temps that were unmeasured. Headache x 4days with feelings of pressure/pounding. Headache is not responsive to treatment with OTC Tylenol/ibuprofen/naproxen.
Hives, raised and itchy. Daily. Never had hives until I got vaccinated for covid 19.
Pfizer booster given after primary Moderna series.  No adverse event reported by patient, only concern about being protected adequately against Covid19.
Patient did not receive a third full dose of the Moderna Covid-19 vaccine as part of their vaccination schedule; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient did not receive a third full dose of the Moderna Covid-19 vaccine as part of their vaccination schedule) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient did not receive a third full dose of the Moderna Covid-19 vaccine as part of their vaccination schedule). At the time of the report, ACCIDENTAL UNDERDOSE (Patient did not receive a third full dose of the Moderna Covid-19 vaccine as part of their vaccination schedule) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No Treatment medications were reported
Patient came in and said he needed his first Pfizer vaccine. After he received the vaccine, it was discovered that he had already had 2 doses, and it has not been 6 months since his second dose.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. On 25-FEB-2013 the patient was vaccinated with improperly stored VARIVAX (Merck) (lot # H018015; expired date: 14-OCT-2013) (dose and route unspecified). The vaccine was stored in refrigeration under 46 degrees Fahrenheit from 07-FEB-2013 to 27-FEB-2013. The outcome of the event was unknown. No adverse effect reported. This is one of the three reports from the same reporter. The MARRS# of the other two reports are 1303USA000093 and 1302USA013682. Additional information has been requested.
Day 1 (Friday 1/14/22) after shot #1 of Moderna  she had 4 bloody noses throughout the day and a swollen lip.  Day 2 (Sat 1/15/22)   after shot #1 of Moderna she had swelling and rash at injection site, which cleared up after 2 doses of Benadryl after consulting with on call physician.    4 days  later (Wed 1/19/22) after shot #1 Moderna she passed out at a team softball practice and was seen in the Emergency Room.   She received her 2nd  COVID vaccine on 2/26/22 and was advised by staff to get the age appropriate PHIZER vaccine as Moderna is not recommended for under 18 yrs of age.   She has had no adverse side effects to the PHIZER vaccine at the time of this report.
Diagnosed with Shingles on 9/23/2019 by Dr.   Valtrex,  started on 9/21/2019.   Pamelor, Flomax started on 9/23/2019.    Lab work on 9/23/2019      Pain and soreness at injection site on 9/17/2019 No symptoms until 9/20/2019  Rash with blisters,  burning pain, Low grade fever, malaise--on right upper groin area, right flank, and right back.
Complained of edema with redness left upper arm and left side below axilla, discomfort, fever, and nausea. Patient relates this started Tuesday night (12/10/02) and seems to be resolving at this time. Patient to see PMD if gets worse with v/d. Follow up states: Have not received forms back from reviewing medical authority.
premenstrual symptoms  Narrative:  Employee reports experienced premenstrual symptoms beginning  approximately 1 week after receiving the second dose of the COVID-19 vaccine.  Reported breast tenderness, lower abdominal cramping, marked fatigue, loose stools, and mild vaginal bleeding. Reported similar reaction after receiving the  first dose as well. Did not use any medications for symptoms this time.  Other Relevant History: